Keywords: gsk, decides, license, exelixis, xl184, uk, drug

GSK decides not to license Exelixis' XL184

Article | 10 November 2008

Print This

UK drug major GlaxoSmithKline says it will not exercise its option to license Exelixis' XL184 nor any of the earlier ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in